| Primary |
| Sedation |
43.3% |
| Sedative Therapy |
16.4% |
| Alcohol Withdrawal Syndrome |
7.5% |
| Drug Use For Unknown Indication |
7.0% |
| General Anaesthesia |
5.0% |
| Product Used For Unknown Indication |
3.5% |
| Procedural Hypotension |
2.0% |
| Schizophrenia |
2.0% |
| Anaesthesia |
1.5% |
| Depression |
1.5% |
| Obesity Surgery |
1.5% |
| Coronary Artery Bypass |
1.0% |
| Delirium |
1.0% |
| Disseminated Intravascular Coagulation |
1.0% |
| Hypotension |
1.0% |
| Mechanical Ventilation |
1.0% |
| Pain |
1.0% |
| Postoperative Analgesia |
1.0% |
| Sleep Apnoea Syndrome |
1.0% |
| Ulcer |
1.0% |
|
| Prothrombin Time Prolonged |
14.5% |
| Cardiac Arrest |
10.5% |
| Hypotension |
10.5% |
| Salivary Hypersecretion |
6.6% |
| Bradycardia |
5.3% |
| Heart Rate Increased |
5.3% |
| Tachycardia |
5.3% |
| Ventricular Fibrillation |
5.3% |
| Liver Disorder |
3.9% |
| Post Procedural Complication |
3.9% |
| Sedation |
3.9% |
| Urticaria |
3.9% |
| Angioedema |
2.6% |
| Atelectasis |
2.6% |
| Atrioventricular Block Second Degree |
2.6% |
| Blood Pressure Decreased |
2.6% |
| Cardiac Tamponade |
2.6% |
| Clonic Convulsion |
2.6% |
| Condition Aggravated |
2.6% |
| Convulsion |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
52.2% |
| Ill-defined Disorder |
13.1% |
| Sedation |
7.0% |
| Infection |
4.8% |
| Constipation |
4.5% |
| Pyrexia |
3.8% |
| Blood Pressure Management |
1.9% |
| Induction Of Anaesthesia |
1.3% |
| Sedative Therapy |
1.3% |
| Aortic Valve Disease |
1.0% |
| Cardiac Failure |
1.0% |
| Cardiac Failure Acute |
1.0% |
| Coronary Artery Bypass |
1.0% |
| Deep Vein Thrombosis |
1.0% |
| Diabetes Mellitus |
1.0% |
| General Anaesthesia |
1.0% |
| Idiopathic Pulmonary Fibrosis |
1.0% |
| Postoperative Analgesia |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Acute Myocardial Infarction |
0.6% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
20.6% |
| White Blood Cell Count Decreased |
8.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
5.9% |
| Hepatitis Fulminant |
5.9% |
| Hypersensitivity |
5.9% |
| Hypotension |
5.9% |
| Lymphocyte Stimulation Test Positive |
5.9% |
| Ventricular Hypokinesia |
5.9% |
| Acidosis |
2.9% |
| Anhedonia |
2.9% |
| Atelectasis |
2.9% |
| Blood Creatine Phosphokinase Increased |
2.9% |
| Fear |
2.9% |
| Liver Disorder |
2.9% |
| Medication Error |
2.9% |
| Musculoskeletal Stiffness |
2.9% |
| Neuroleptic Malignant Syndrome |
2.9% |
| Pyrexia |
2.9% |
| Renal Injury |
2.9% |
| Respiratory Arrest |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.5% |
| Sedation |
11.1% |
| Fluid Replacement |
7.4% |
| Prophylaxis |
7.3% |
| Drug Use For Unknown Indication |
5.5% |
| Infection |
5.1% |
| Coronary Artery Bypass |
3.6% |
| Cardiac Failure |
3.1% |
| Pyrexia |
2.8% |
| Renal Transplant |
2.8% |
| Ureteral Stent Insertion |
2.8% |
| Ureteral Stent Removal |
2.8% |
| Hypertension |
2.6% |
| Infection Prophylaxis |
2.6% |
| Insomnia |
2.5% |
| Small Intestine Carcinoma |
2.3% |
| Diuretic Therapy |
2.2% |
| Pneumonia |
2.2% |
| Diabetes Mellitus |
2.1% |
| Cardiac Failure Congestive |
1.8% |
|
| Renal Failure Acute |
9.2% |
| Respiratory Failure |
9.2% |
| Urine Output Decreased |
7.9% |
| Injury |
6.6% |
| Pulmonary Oedema |
6.6% |
| Septic Shock |
6.6% |
| Fear |
5.3% |
| Multi-organ Failure |
5.3% |
| Unevaluable Event |
5.3% |
| Anxiety |
3.9% |
| Cardiac Failure |
3.9% |
| Death |
3.9% |
| Interstitial Lung Disease |
3.9% |
| Pain |
3.9% |
| Post Procedural Complication |
3.9% |
| Renal Injury |
3.9% |
| Arteriosclerosis Obliterans |
2.6% |
| Blood Creatinine Increased |
2.6% |
| Bronchitis |
2.6% |
| Cerebral Haemorrhage |
2.6% |
|
| Interacting |
| General Anaesthesia |
42.9% |
| Sedative Therapy |
28.6% |
| Cardiac Operation |
14.3% |
| Pain |
7.1% |
| Procedural Nausea |
7.1% |
|
|
